Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05480124 · ClinicalTrials.gov registry record · NA
Bipolar Transcranial Alternating Current Stimulation (tACS)
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT05480124 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 18 participants.
The verdict
NCT05480124, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to measure the safety and effectiveness of a non-invasive brain stimulation device called Transcranial Alternating Current Stimulation (tACS) in participants with bipolar disorder (BD). Participants will be asked to come in for 3 sessions. If participants qualify at the screening visit (session 1) then enrolled participants will complete sessions 2 and 3 as well as have a 30-day follow-up phone call.
Interventions
- DEVICE tACS brain stimulation treatment
- DEVICE Sham stimulation treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2023-04-20 |
| Est. Completion | 2024-01-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05480124
The ClinicalTrials.gov registry entry for NCT05480124 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which tACS brain stimulation treatment is the first listed.
NCT05480124 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05480124 about?
NCT05480124 is a clinical study titled "Bipolar Transcranial Alternating Current Stimulation (tACS)". The purpose of this clinical trial is to measure the safety and effectiveness of a non-invasive brain stimulation device called Transcranial Alternating Current Stimulation (tACS) in participants with bipolar disorder (BD). Participants will be asked to come in for 3 sessions. If participants quali...
What is the current status of trial NCT05480124?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2023-04-20. Estimated completion is 2024-01-06.
What interventions are being tested in trial NCT05480124?
The interventions under investigation include: tACS brain stimulation treatment (DEVICE), Sham stimulation treatment (DEVICE).
Who is sponsoring clinical trial NCT05480124?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.